| Medical and Health Sciences | Lifetime | 543 | CA 30 | 99.98 |
| Internal Medicine | Lifetime | 6 | CA 3 | 99.78 |
| Cardiology and Cardiovascular Medicine | Lifetime | 204 | CA 14 | 99.74 |
| Surgery | Lifetime | 568 | CA 29 | 99.47 |
| Hematology | Lifetime | 245 | CA 11 | 98.62 |
| Rheumatology | Lifetime | 734 | CA 37 | 96.28 |
| Statistics, Probability and Uncertainty | Lifetime | 671 | CA 58 | 92.69 |
| Medical Genetics | Lifetime | 954 | CA 27 | 87.36 |
| Medical Biochemistry | Lifetime | 630 | CA 20 | 75.68 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 594 | CA 38 | 90.16 |
| Internal Medicine | 2021-2025 | 94 | CA 12 | 87.02 |
| Rheumatology | 2021-2025 | 376 | CA 22 | 84.80 |
| Hematology | 2021-2025 | 357 | CA 18 | 81.27 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 6 | CA 2 | 99.94 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 1 | CA 1 | 99.79 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 19 | CA 6 | 99.93 |
| Vitamin K Research Studies | Lifetime | 7 | CA 1 | 99.24 |
| Platelet Disorders and Treatments | Lifetime | 48 | CA 4 | 99.37 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 52 | CA 8 | 99.32 |
| Central Venous Catheters and Hemodialysis | Lifetime | 85 | CA 12 | 99.17 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 175 | CA 16 | 99.07 |
| Acute Myocardial Infarction Research | Lifetime | 249 | CA 12 | 99.16 |
| Blood groups and transfusion | Lifetime | 216 | CA 11 | 98.23 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 44 | CA 4 | 97.74 |
| Systemic Lupus Erythematosus Research | Lifetime | 454 | CA 20 | 98.57 |
| Hemoglobinopathies and Related Disorders | Lifetime | 582 | CA 11 | 97.19 |
| Cardiac Arrhythmias and Treatments | Lifetime | 900 | CA 59 | 97.87 |
| Ultrasound in Clinical Applications | Lifetime | 264 | CA 20 | 96.62 |
| Blood transfusion and management | Lifetime | 274 | CA 32 | 95.93 |
| Case Reports on Hematomas | Lifetime | 67 | CA 4 | 95.62 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 361 | CA 24 | 95.55 |
| Intramuscular injections and effects | Lifetime | 61 | CA 12 | 94.28 |
| Clinical practice guidelines implementation | Lifetime | 589 | CA 83 | 94.44 |
| Meta-analysis and systematic reviews | Lifetime | 418 | CA 60 | 94.91 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 693 | CA 42 | 93.42 |
| Blood disorders and treatments | Lifetime | 854 | CA 39 | 92.16 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 412 | CA 31 | 95.63 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 649 | CA 37 | 95.65 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 776 | CA 24 | 90.71 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 197 | CA 13 | 88.46 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 187 | CA 11 | 82.68 |
| Platelet Disorders and Treatments | 2021-2025 | 594 | CA 26 | 85.25 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 936 | CA 25 | 50.30 |
| Case Reports on Hematomas | 2021-2025 | 489 | CA 7 | 28.39 |
